医美界最大忽悠，栽了

Core Viewpoint - The article discusses the exposure of a major fraud involving Jiangsu Wuzhong (*ST Suwu), a company that misled investors and engaged in long-term deception, leading to its forced delisting from the stock market [1][2]. Group 1: Company Background - Jiangsu Wuzhong, originally established in 1994, has undergone multiple transformations, including ventures into textiles, real estate, and chemicals, before entering the medical aesthetics industry [4][6]. - The company gained attention in the medical aesthetics sector through its subsidiary, Wuzhong Aesthetics, which marketed the popular "AestheFill" product [3][4]. Group 2: Fraudulent Activities - Jiangsu Wuzhong has been involved in systematic fraud, including false disclosures about its actual controllers and inflated financial figures, with a significant amount of funds misappropriated [9][10]. - The company engaged in a "hot potato" scheme, where different controllers participated in the deception, ultimately leaving investors to bear the losses [2][9]. Group 3: Regulatory Actions - Regulatory authorities have initiated major illegal delisting procedures against Jiangsu Wuzhong due to severe violations, including a fine of 15 million yuan for its actual controller, Qian Qunshan, and a ten-year ban from the securities market [10][12]. - The company is now facing legal challenges, including a lawsuit against Aimeike for trademark infringement, as it seeks to recover 1.6 billion yuan in damages [11][12].